Respiratory infections and asthma: Current treatment strategies

Drug Discovery Today

Volumn 9, Issue 19, 2004, Pages 831-837

  Weinberger, Miles ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Chemical Biology; Drug Discovery; Intercellular adhesion molecule 1; Pharmaceutical Science; Respiratory syncytial virus; Rhinovirus; Upper respiratory infection; Viral respiratory infections; Virology

Indexed keywords

A 60444; ALUMINUM POTASSIUM SULFATE; ANTIVIRUS AGENT; BRONCHODILATING AGENT; CFY 196; CLARITHROMYCIN; CORTICOSTEROID; DEXAMETHASONE; ERYTHROMYCIN; HYBRID PROTEIN; IMMUNOGLOBULIN; INACTIVATED VACCINE; INTERCELLULAR ADHESION MOLECULE 1; METHYLPREDNISOLONE; PALIVIZUMAB; PREDNISOLONE; PREDNISONE; RECOMBINANT INTERCELLULAR ADHESION MOLECULE 1; RESPIRATORY SYNCYTIAL VIRUS VACCINE; RF 1641; RIBAVIRIN; UNCLASSIFIED DRUG; VP 14637;

ASTHMA; BACTERIAL INFECTION; BRONCHIOLITIS; CHILD HOSPITALIZATION; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; DISEASE EXACERBATION; HAEMOPHILUS INFLUENZAE TYPE A; HUMAN; HUMAN RHINOVIRUS; MYCOPLASMA PNEUMONIA; MYCOPLASMA PNEUMONIAE; NONHUMAN; PROTEIN ANALYSIS; RESPIRATORY EPITHELIUM; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY TRACT INFECTION; REVIEW; RHINOVIRUS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VIRUS INFECTION;

ACUTE DISEASE; ASTHMA; HUMANS; RESPIRATORY TRACT INFECTIONS;

EID: 4644219548     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(04)03239-8     Document Type: Review

References (68)

1. Lemanske R.F. Jr. Viruses and asthma: inception, exacerbations, and possible prevention. J. Pediatr. 142:2003;S3-S8
2. Glezen W.P., et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am. J. Dis. Child. 140:1986;543-546
3. Shay D.K., et al. Bronchiolitis-associated hospitalizations among US children, 1980-1996. J. Am. Med. Assoc. 282:1999;1440-1446
4. Sims D.G., et al. Study of 8-year-old children with a history of respiratory syncytial virus bronchiolitis in infancy. Br. Med. J. 1:1978;11-14
5. Gurwitz D., et al. Increased incidence of bronchial reactivity in children with a history of bronchiolitis. J. Pediatr. 98:1981;551-555
6. Welliver R.C., et al. Predictive value of respiratory syncytial virus-specific IgE responses for recurrent wheezing following bronchiolitis. J. Pediatr. 109:1986;776-780
7. Sigurs N., et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161:2000;1501-1507
8. Weinberger M., et al. Clinical patterns and natural history of asthma. J. Pediatr. 142:(Suppl. 2):2003;S15-S20
9. McIntosh K., et al. The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J. Pediatr. 82:1973;578-590
10. Minor T.E., et al. Viruses as precipitants of asthmatic attacks in children. J. Am. Med. Assoc. 227:1974;292-298
11. Nicholson K.G., et al. Respiratory viruses and exacerbations of asthma in adults. Br. Med. J. 307:1993;982-986
12. Johnston S.L., et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med. J. 310:1995;1225-1229
13. Rakes G.P., et al. Rhinovirus and respiratory syncytial virus in wheezing children requiring emergency care: IgE and eosinophil analyses. Am. J. Respir. Crit. Care Med. 159:1999;785-790
14. Dales R.E., et al. Respiratory infections and the autumn increase in asthma morbidity. Eur. Respir. J. 9:1996;72-77
15. Rosenstein N., et al. The common cold - principles of judicious use of antimicrobial agents. Pediatrics. 101:1998;181-184
16. Akinbami L.J., Schoendorf K.C. Trends in childhood asthma: prevalence, health care utilization, and mortality. Pediatrics. 110:2002;315-322
17. Chew F.T., Lee B.W. Utilization of healthcare resources for asthma in Singapore: demographic features and trends. Asian Pac. J. Allergy Immunol. 16:1998;57-68
18. Korhonen K., et al. Hospitalization trends for paediatric asthma in eastern Finland: a 10 year survey. Eur. Respir. J. 19:2002;1035-1039
19. Engelsvold D.H., Oymar M. Hospital admissions for childhood asthma in Rogaland, Norway from 1984 to 2000. Acta Paediatr. 92:2003;610-616
20. Johnston S.L., et al. The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am. J. Respir. Crit. Care Med. 154:2002;654-660
21. Jartti T., et al. Metapneumovirus and acute wheezing in children. Lancet. 360:2002;1393-1394
22. Peiris J.S., et al. Children with respiratory disease associated with metapneumovirus in Hong Kong. Emerg. Infect. Dis. 9:2003;628-633
23. Rawlinson W.D., et al. Asthma exacerbations in children associated with rhinovirus but not human metapneumovirus infection. J. Infect. Dis. 187:2003;1314-1318
24. Williams J.V., et al. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350:2004;443-450
25. Martin R.J., et al. A link between chronic asthma and chronic infection. J. Allergy Clin. Immunol. 107:2001;595-601
26. Jones K., Gruffydd-Jones K. Management of acute asthma attacks associated with respiratory tract infection: a postal survey of general practitioners in the UK. Respir. Med. 90:1996;419-425
27. Henderson M., Rubin E. Misuse of antimicrobials in children with asthma and bronchiolitis: a review. Pediatr. Infect. Dis. J. 20:2001;214-215
28. Shapiro G.G., et al. Double-blind study of the effectiveness of a broad-spectrum antibiotic in status asthmaticus. Pediatrics. 53:1974;867-872
29. Graham V.A., et al. Routine antibiotics in hospital management of acute asthma. Lancet. 1:1982;418-420
30. Sachs A.P., et al. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patents with chronic obstructive pulmonary disease in general practice. Thorax. 50:1995;758-763
31. Kraft M., et al. Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin. Chest. 121:2002;1782-1788
32. Beuther D.A., Martin R.J. Antibiotics in asthma. Curr. Allergy Asthma Rep. 4:2004;132-138
33. Storr L., et al. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1:1987;879-882
34. Tal A., et al. Methylprednisolone therapy for acute asthma in infants and toddlers: a controlled clinical trial. Pediatrics. 86:1990;350-356
35. Scarfone R.J., et al. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 92:1993;513-518
36. Schuh S., et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J. Pediatr. 140:2002;27-32
37. Weinberger M., et al. Corticosteroids for first time young wheezers: current status of the controversy. J. Pediatr. 143:2003;700-702
38. Harris J.B., et al. Early intervention with short courses of prednisone to prevent progression of asthma in ambulatory patients incompletely responsive to bronchodilators. J. Pediatr. 110:1987;627-644
39. Brunette M.G., et al. Childhood asthma: prevention of attacks with short-term corticosteroid treatment of upper respiratory tract infection. Pediatrics. 81:1988;624-629
40. Weinberger M., et al. Commentary - corticosteroids for exacerbations of asthma: current status of the controversy. Pediatrics. 81:1988;726-729
41. Weinberger M., et al. Corticosteroids for exacerbations of asthma: problems and solutions. J. Pediatr. 136:2000;276-278
42. Weinberger M., et al. Treatment strategies for viral respiratory infection-induced asthma. J. Pediatr. 142:(Suppl. 2):2003;S34-S39
43. Ducharme F.M., et al. Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function. Pediatrics. 111:2003;376-383
44. Doull I.J. Limitations of maintenance therapy for viral respiratory infection-induced asthma. J. Pediatr. 142:2003;S21-S25
45. Wilson N., et al. Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children. Arch. Dis. Child. 72:1995;317-320
46. Stick S.M., et al. The effects of inhaled beclomethasone dipropionate on lung function and histamine responsiveness in recurrently wheezy infants. Arch. Dis. Child. 73:1995;327-332
47. Doull I.J., et al. Effect of inhaled corticosteroids on episodes of wheezing associated with viral infection in school age children: randomized double-blind placebo-controlled trial. Br. Med. J. 315:1997;858-862
48. McKean, M. and Ducharme, F. (2004) Inhaled steroids for episodic viral wheeze of childhood (Cochrane Review). In The Cochrane Library, Issue 3, John Wiley & Sons
49. Grunberg K., et al. Experimental rhinovirus 16 infection increase intracellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin. Exp. Allergy. 30:2000;1015-1023
50. Rodriguez W., et al. Respiratory syncytial virus immune globulin intravenous therapy for RSV lower respiratory tract infection in infants and young children at high risk for severe RSV infections. Pediatrics. 99:1997;454-461
51. Rodriguez W., et al. Respiratory syncytial virus immune globulin treatment of RSV lower respiratory tract infection in previously healthy children. Pediatrics. 100:1997;937-946
52. The Impact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 102:1998;531-537
53. Kapikian A.Z., et al. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am. J. Epidemiol. 89:1969;405-421
54. Kim H.W., et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89:1969;422-434
55. Prince G.A., et al. Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactivated virus. J. Virol. 57:1986;721-728
56. Connors M., et al. Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:1994;5321-5325
57. Openshaw P.J., et al. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine. 20:(Suppl. 1):2001;S27-S31
58. Polack F.P., Karron R.A. The future of respiratory syncytial virus vaccine development. Pediatr. Infect. Dis. J. 23:2004;S65-S73
59. Edell D., et al. Early ribavirin treatment of bronchiolitis: effect on long-term respiratory morbidity. Chest. 122:2002;935-939
60. Guerguerian A.M., et al. Ribavirin in ventilated respiratory syncytial virus bronchiolitis. A randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 160:1999;829-834
61. Maggon M., Sailen B. New drugs and treatment for respiratory syncytial virus. Rev. Med. Virol. 14:2004;149-168
62. Suzuki T., et al. Erythromycin inhibits rhinovirus infection in cultured human tracheal epithelial cells. Am. J. Respir. Crit. Care Med. 165:2002;1113-1118
63. Greve J.M., et al. The major human rhinovirus receptor is ICAM-1. Cell. 56:1989;839-847
64. Staunton D.E., et al. A cell adhesion molecule, ICAM-1 is the major surface receptor for rhinoviruses. Cell. 56:1989;849-853
65. Hayden F.G., et al. Modification of experimental rhinovirus colds by receptor blockade. Antiviral Res. 9:1988;233-247
66. Charles C.H., et al. Prevention of human rhinovirus infection by multivalent fab molecules directed against ICAM-1. Antimicrob. Agents Chemother. 47:2003;1503-1508
67. Fang F., Yu M. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196. J. Antimicrob. Chemother. 53:2004;23-25
68. Turner R.B., et al. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection: a randomized clinical trial. J. Am. Med. Assoc. 281:1999;1797-11804